In the real-world, Pluvicto™ showed 13.5 months median PFS in chemo-naïve patients with PSMA-positive mCRPC; Real‑world evidence showed Pluvicto achieved longer PFS when init ...
Phase III program in food allergy (FA) planned for H2 2026 ...
At Novartis, we innovate, develop and operate on a vast scale. You can be part of it. Join our creative community of professionals and you will find opportunities to make an unprecedented impact – on ...
Bli en del av Novartis, här kan du se mer om vilka karriärmöjligheter som finns.
Utforsk mulighetene hos Novartis og Sandoz her. Se mer informasjon om stillinger hos Novartis Gene Therapies på GTx Career Search.
Part of a USD 23 billion US investment to expand R&D and advanced manufacturing to reach more patients East Hanover, February 6, 2026 – Novartis today broke ground on a new, state-of-the-art global ...
V Novartisu spodbujamo inovativnost in razvoj ter delujemo na številnih področjih. Tudi vi lahko postanete del tega, del naše zgodbe. Pridružite se naši ustvarjalni skupnosti strokovnjakov in našli ...
Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search.
Auditoría y Finanzas BD&L & Strategic Planning Communications & Public Affairs Data and Digital Gerencia Comercial y General Instalaciones y Administración Interns/Students on Novartis Payroll Market ...
Лікарські засоби Novartis, зареєстровані в Україні ...
Tutvuge allpool olevate Novartise võimalustega. Market Access Manager (80-100%*) (temp role 12 months) Befristet (Innendienst) (Befristet), Full time Strategic Planning & BD&L Switzerland Rotkreuz ...
Ανακαλύπτουμε και αναπτύσσουμε πρωτοποριακές θεραπείες και βρίσκουμε νέους τρόπους για ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results